Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
DNLI | Denali Therapeutics Inc. | Chief Medical Officer | $3 M | -$605 K | -16.8% | Feb 13, 2024 |
BEAM | Beam Therapeutics Inc. | Director | $564 K | Jun 5, 2024 | ||
NGM | NGM BIOPHARMACEUTICALS INC | Director | Apr 5, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|